These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers. Keith RL; Blatchford PJ; Merrick DT; Bunn PA; Bagwell B; Dwyer-Nield LD; Jackson MK; Geraci MW; Miller YE Cancer Prev Res (Phila); 2019 Oct; 12(10):721-730. PubMed ID: 31308004 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Szabo E; Mao JT; Lam S; Reid ME; Keith RL Chest; 2013 May; 143(5 Suppl):e40S-e60S. PubMed ID: 23649449 [TBL] [Abstract][Full Text] [Related]
6. Development of chemopreventive agents for lung and upper aerodigestive tract cancers. Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195 [TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of lung cancer. Keith RL Proc Am Thorac Soc; 2009 Apr; 6(2):187-93. PubMed ID: 19349487 [TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of aerodigestive cancer. Berwick M; Schantz S Cancer Metastasis Rev; 1997; 16(3-4):329-47. PubMed ID: 9433643 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of lung cancer: new directions. Szabo E; Kalebic T Recent Results Cancer Res; 2003; 163():172-81; discussion 264-6. PubMed ID: 12903853 [TBL] [Abstract][Full Text] [Related]
10. Lung cancer chemoprevention: current status and future prospects. Keith RL; Miller YE Nat Rev Clin Oncol; 2013 Jun; 10(6):334-43. PubMed ID: 23689750 [TBL] [Abstract][Full Text] [Related]
11. Lung cancer chemoprevention. Keith RL Proc Am Thorac Soc; 2012 May; 9(2):52-6. PubMed ID: 22550242 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer. Decensi A; Costa A Eur J Cancer; 2000 Apr; 36(6):694-709. PubMed ID: 10762741 [TBL] [Abstract][Full Text] [Related]
13. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933 [TBL] [Abstract][Full Text] [Related]
15. Designing a randomized phase I/II prostate cancer chemoprevention trial using 1alpha-hydroxy-24-ethyl-cholecalciferol, an analogue of vitamin D3. Packianathan S; Mehta RG; Mehta RR; Hall WH; Boerner PS; Beckett LA; Vijayakumar S Cancer J; 2004; 10(6):357-67. PubMed ID: 15701267 [TBL] [Abstract][Full Text] [Related]
16. The finding of premalignant lesions is not associated with smoking cessation in chemoprevention study volunteers. Schook RM; Postmus BB; van den Berg RM; Sutedja TG; Man de FS; Smit EF; Postmus PE J Thorac Oncol; 2010 Aug; 5(8):1240-5. PubMed ID: 20581710 [TBL] [Abstract][Full Text] [Related]
17. Methods and strategies in lung cancer control. Castonguay A Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994 [TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial of sulindac for lung cancer chemoprevention. Limburg PJ; Mandrekar SJ; Aubry MC; Ziegler KL; Zhang J; Yi JE; Henry M; Tazelaar HD; Lam S; McWilliams A; Midthun DE; Edell ES; Rickman OB; Mazzone P; Tockman M; Beamis JF; Lamb C; Simoff M; Loprinzi C; Szabo E; Jett J; Lung Cancer; 2013 Mar; 79(3):254-61. PubMed ID: 23261228 [TBL] [Abstract][Full Text] [Related]
19. Lung cancer chemoprevention: moving from concept to a reality. Mulshine JL; Hirsch FR Lung Cancer; 2003 Aug; 41 Suppl 1():S163-74. PubMed ID: 12867075 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of lung cancer. van Zandwijk N Lung Cancer; 2001 Dec; 34 Suppl 3():S91-4. PubMed ID: 11741000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]